percentage of americans taking glp 1 Some 22% American women and 14% of men have taken GLP-1s for weight loss or for chronic conditions such as diabetes. In charts we show the social and economic effects: bit.ly/44MJFWn Just how many Americans are

Branded GLP-1 Therapies in 2026 Wegovy represents branded semaglutide at fixed doses

One store may see softening across traditional center-store categories while a nearby location picks up stronger movement in fresher, higher-protein, or smaller-portion products

Scientific Publication Patterns by Theme The scientific literature from 2020 through 2025 reveals parallel trends, with publication volume concentrated in areas that mirror patent activity

Cerebrovascular function Optimal function of cerebral conduit arteries is another critical factor in ensuring CBF matches the metabolic demands for brain function and maintain long-term brain health

However, too long a delay in bringing these drugs to an employer-sponsored plan could mean a disadvantage in recruitment and retention, as well as a decline in productivity and overall health of population

At Cymbiotika, we believe that understanding the science of delivery is just as important as the quality of the ingredients themselves